rac-Letermovir-d8

SL-8454

rac-Letermovir-d₈, >98%

IUPAC Name : 2-(8-Fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl-d₈)-3,4-dihydroquinazolin-4-yl)acetic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Letermovir, which is a novel anti-CMV compound, that targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors. Additionally, it serves as a research chemical related to COVID-19.

References : Goldner T. et al.: J. Virol., 85(20), 10884-93, 2011; Lischka P. et al.: Antimicrob Agents Chemother., 54(3), 1290-7, 2010.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.